GLP-1 supplements ... and the brand says it’ll be on shelves within the year. “The way people eat is changing. Whether it’s plant-based, high-protein, or now GLP-1-conscious, food should ...

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...

Supergut is setting sights on bold retail expansion with the help of fresh capital and new executive leadership with a track record for solving supply chain challenges.

People are taking tiny amounts of GLP-1, short for glucagon-like peptide 1 and sold under brand names like Ozempic, Wegovy and Mounjaro to treat diabetes and obesity. Sarah Laing is a Toronto ...

Discontinuation was defined as 60 days without any GLP-1 RA on hand. Reinitiation was defined as the first fill of any GLP-1 RA after discontinuation. Patients were followed for up to two years ...

Preoperative glucagon-like peptide-1 receptor agonist use is not associated with short-term postoperative aspiration pneumonia.

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...

"This finding suggests that it may be beneficial to reassess the preoperative withholding guidelines for GLP-1 RAs." HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 ...

They matched each GLP-1 RA user with a kidney transplant recipient who had not started a GLP-1 RA, was alive with a functioning graft, and had accrued identical posttransplant survival time.

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with type 2 diabetes is linked to a reduced risk of developing certain hematologic cancers compared to insulin and metformin.